ArticleJournal of translational medicine2024

Advancing targeted combination chemotherapy in triple negative breast cancer: nucleolin aptamer-mediated controlled drug release.

Yuan Ma et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.